News Releases

Bodisen Biotech Will Report Year 2005 Audited Financials on Tuesday March 28th 2006 at 8AM Eastern Standard Time
Monday March 27, 11:49 am ET

NEW YORK--(BUSINESS WIRE)--March 27, 2006--Bodisen Biotech, Inc. (AMEX:BBC, London AIM: BODI, website /) the first China based environmentally friendly bio fertilizer company listed on a US stock exchange, and dually listed in London, will report US GAAP based 2005 audited financials and file SEC annual report 10K on Tuesday, March 28th 2006.

About Bodisen Biotech, Inc.

A Delaware company, Bodisen is headquartered in Shaanxi, China's agricultural hub. The Bodisen brand is a highly recognized fertilizer brand in China. Its environmentally friendly "green" products support the mandate of the Chinese government to increase crop yields for the purpose of decreasing China's dependency on food imports. Utilizing proprietary agricultural technologies, Bodisen sells over 60 packaged products, broken down into 4 product categories: Organic Compound Fertilizer; Organic Liquid Fertilizer; Pesticides & Insecticides, and agricultural raw materials. Bodisen's organic fertilizers can be absorbed by plants within 48 hours and enrich soil conditions without the damaging effects associated with chemical fertilizers. These products address grains, vegetables, and fruit crops and have been proven to increase crop yields by 10% to 35% while being 100% environmentally friendly. Among China's population of 1.3 billion, approximately 900 million are farmers whose incomes depend on their crop yields. With approximately 600 (and growing) nationwide distribution centers, Bodisen has experienced rapid growth in its existing business.

Safe Harbor Statement

This press release may contain forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statements are based on the current expectations or beliefs of Bodisen Biotech, Inc. management and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements.


Contact:
The Piacente Group, Inc.
Investor Relations: 
Debra Chen, 212-481-1907
debra@thepiacentegroup.com
________________________________________
Source: Bodisen Biotech, Inc.

 

Copyright © 2004 bodisen.com